ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,287.30
0.07%
Dow Jones
44,910.65
0.42%
Gold vs US Dollar
2,649.87
0.00%
Brent Oil
71.98
-0.08%
Bitcoin
96,441.26
-1.07%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. TC BioPharm Holdings PLC (TCBP)

  7. TC BioPharm Holdings PLC (TCBP) News

TC BioPharm (TCBP)

TC BioPharm Holdings PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TCBP
DateTimeSourceHeadlineSymbolCompany
12/11/202414:30PR Newswire (US)TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® GrantNASDAQ:TCBPTC BioPharm Holdings PLC
30/10/202412:30PR Newswire (US)TCBP Provides Shareholder Update and Highlights Recent Milestone AchievementsNASDAQ:TCBPTC BioPharm Holdings PLC
25/10/202413:45PR Newswire (US)TCBP Responds to False Social Media ClaimNASDAQ:TCBPTC BioPharm Holdings PLC
22/10/202417:45AllPennyStocks.comBiotech Shares Rip Following Collaboration Announcement For Monkeypox ResearchNASDAQ:TCBPTC BioPharm Holdings PLC
22/10/202412:30PR Newswire (US)TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox TherapeuticNASDAQ:TCBPTC BioPharm Holdings PLC
03/10/202412:30PR Newswire (US)TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor ScreeningNASDAQ:TCBPTC BioPharm Holdings PLC
25/09/202412:30PR Newswire (US)TCBP Announces Site Opening of Guys and St. Thomas HospitalNASDAQ:TCBPTC BioPharm Holdings PLC
24/09/202412:45PR Newswire (US)TCBP to Present at the 2024 ThinkEquity Conference in NYCNASDAQ:TCBPTC BioPharm Holdings PLC
20/09/202420:00PR Newswire (US)/C O R R E C T I O N -- TC BioPharm/NASDAQ:TCBPTC BioPharm Holdings PLC
12/09/202412:30PR Newswire (US)TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical TrialNASDAQ:TCBPTC BioPharm Holdings PLC
09/09/202412:30PR Newswire (US)TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey PoxNASDAQ:TCBPTC BioPharm Holdings PLC
06/09/202420:00PR Newswire (US)TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey PoxNASDAQ:TCBPTC BioPharm Holdings PLC
05/09/202412:30PR Newswire (US)TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TCBPTC BioPharm Holdings PLC
03/09/202412:30PR Newswire (US)TCBP Announces Dosing of 5 New Patients in ACHIEVENASDAQ:TCBPTC BioPharm Holdings PLC
30/08/202419:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
29/08/202421:11Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:TCBPTC BioPharm Holdings PLC
28/08/202422:32Edgar (US Regulatory)Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]NASDAQ:TCBPTC BioPharm Holdings PLC
28/08/202421:15PR Newswire (US)TC BioPharm Announces Closing of Upsized $6.0 Million Public OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
28/08/202417:50PR Newswire (US)TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral IndicationsNASDAQ:TCBPTC BioPharm Holdings PLC
23/08/202421:30Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:TCBPTC BioPharm Holdings PLC
23/08/202420:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
16/08/202420:20Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:TCBPTC BioPharm Holdings PLC
15/08/202417:00PR Newswire (US)TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b)NASDAQ:TCBPTC BioPharm Holdings PLC
15/08/202415:30PR Newswire (US)TC BioPharm Announces Closing of $2.0 Million Public OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
15/08/202414:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
14/08/202411:30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:TCBPTC BioPharm Holdings PLC
13/08/202420:30PR Newswire (US)TC BioPharm Announces Pricing of $2.0 Registered Direct OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
13/08/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TCBPTC BioPharm Holdings PLC
08/08/202420:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
06/08/202420:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
 Showing the most relevant articles for your search:NASDAQ:TCBP

Your Recent History

EU
DIEG
Diegem Kennedy Cert
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 50%* for Level 2 Lite

    1 year 30%, 2 years 40% and *3 years 50%

    *Across 3 years £2132.64 only 1066.32